Delhi High Court Upholds Rejection Of Blackberry Patent On Colour-Coding Message Recipients Feature

The Delhi High Court has dismissed an appeal filed by Blackberry Limited, upholding the refusal of a patent application for a feature that colour-coded message recipients meant to help users distinguish between recipients before sending messages. In a judgment pronounced on April 30, 2026, Justice Tejas Karia held that the invention was unpatentable under Section 3(k) of the Patents Act as a computer program per se and also lacked an inventive step. The Court observed that the problem of...

Supreme Court Issues Notice On Plea Against Delhi HC Ruling That Patent Revocation Plea Survives Expiry

The Supreme Court on Monday issued notice on a plea challenging a Delhi High Court ruling that a patent revocation petition remains maintainable and survives even after expiry of the patent and is not barred merely because an invalidity defence is raised in a parallel infringement suit. A Bench of Justices P.S. Narasimha and Alok Aradhe issued notice on the special leave petition filed by by Boehringer Ingelheim Pharma GmbH and listed the matter for final disposal on May 25, 2026 The case...

Delhi High Court Sets Aside Nippon Steel Patent Rejection, Says Orders Must Give Reasons

The Delhi High Court has set aside the refusal of a patent application filed by Nippon Steel Corporation, holding that an order which merely reproduces prior art documents without analyzing the claimed invention or giving reasons cannot be sustained in law.A bench of Justice Tushar Rao Gedela emphasised that patent authorities act as quasi-judicial bodies and must pass reasoned orders. “It is apparent that the Assistant Controller/Controller are quasi judicial authorities from whom it is...

Delhi High Court Dismisses NEC's Patent Appeal, Holds Video Coding Invention Obvious In Light Of Prior Art

The Delhi High Court has dismissed an appeal filed by NEC Corporation challenging the rejection of its patent application relating to video coding and decoding technologies, holding that the claimed invention lacks an inventive step and is rendered obvious in light of prior art documents. A Bench of Justice Tejas Karia held: “the contentions advanced by the Appellant that D1 to D3 are confined merely to colour space conversion or switching, akin to transformation in the present invention, and...

Delhi High Court Upholds Canadian Company's Antenna Patent, Finds Rosenberger In Infringement

The Delhi High Court has ruled in favour of Canadian firm Communication Components Antenna Inc. in a patent infringement dispute, turning down the defendants' challenge to the validity of its patent covering split-sector antenna technology that uses asymmetrical beams. The Court also held that companies within the Rosenberger Group had infringed the invention. In a judgment delivered on March 30, 2026, Justice Prathiba M. Singh upheld the patent as valid and enforceable. The Court found that...

Delhi High Court Sets Aside Order Refusing Patent For Harvard's Insulin-Producing Pancreatic Cells

The Delhi High Court has set aside an order by the Controller General of Patents that refused a patent to Harvard College for its stem-cell-derived insulin-producing pancreatic cells used for diabetes treatment. Justice Tejas Karia held that the Patent Office committed an error by failing to consider the university's amended claims, which had significantly altered the nature of the application. Harvard had filed an appeal under Section 117 of the Patents Act against the Controller General...

Delhi High Court Sets Aside Patent Refusal, Says New Objections In Final Order Violate Natural Justice

The Delhi High Court has quashed an order by the Assistant Controller of Patents refusing a patent application by Wirtgen GMBH, ruling that the introduction of new technical objections for the first time in a final refusal order violates the fundamental principles of natural justice.Justice Manmeet Pritam Singh Arora held on March 23, 2026, that the impugned order was procedurally infirm as it deprived the applicant of a fair opportunity to address the specific grounds of refusal."If...

Bombay High Court Quashes Patent Refusal To Medipack, Says Reasons Are 'Heart And Soul' Of Orders

The Bombay High Court on 23 March set aside the Patent Office's refusal to grant a patent for a single-use safety syringe to Medipack Global Ventures Pvt. Ltd., holding that the order was unreasoned and violated the principles of natural justice. A Single-Judge Bench of Justice Arif S. Doctor set aside the impugned order and remanded the matter for fresh consideration by a different Controller. It remarked: “Section 117A of the Patents Act specifically provides for an appeal against any order...

Delhi High Court Records Interim Arrangement In Novo Nordisk–Torrent Pharma Patent Dispute Over Semaglutide

The Delhi High Court has recorded an interim arrangement between Danish pharmaceutical company Novo Nordisk and Torrent Pharmaceuticals Limited in a patent infringement suit concerning semaglutide, a compound used in the popular diabetes and weight-loss drug Ozempic. Justice Tushar Rao Gedela on March 20, 2026, recorded that the parties had agreed to an interim arrangement under which the Torrent would ensure that the concentration of a specific chemical component in its product does not fall...

Delhi High Court Upholds Rejection Of Patent For Cancer Screening Method, Calls It Non-Patentable Diagnostic Process

The Delhi High Court has upheld the rejection of a patent application filed by the biopharmaceutical firm Geron Corporation for a method aimed at selecting cancer patients for specialized therapy.Justice Manmeet Pritam Singh Arora, on March 17, 2026, held that the proposed “in vitro screening method” functions as a diagnostic process, which is barred from patentability under Section 3(i) of the Patents Act. The court observed that regardless of whether a test is labeled as "screening" or...

Bombay High Court Remands Pharmaceutical Patent Opposition, Sets Aside Patent Office Order As Unreasoned

The Bombay High Court has set aside an order of the Deputy Controller of Patents that had dismissed a post-grant opposition, finding that the decision contained no real reasoning and did not include the technical analysis required under the law. In a judgment dated March 10, 2026, Justice Arif S. Doctor noted that the patent office had rejected the prior-art claim relied on by the opponent without explaining the basis for doing so. The Court said that because the order was appealable, the...

Delhi High Court Upholds Order Refusing Interim Relief To Novo Nordisk In Semaglutide Patent Dispute With Dr Reddy's

The Delhi High Court on Monday dismissed Danish Pharma Company Novo Nordisk's appeal seeking an interim injunction against Dr Reddy's Laboratories Ltd in a patent infringement dispute over the anti-diabetic drug Semaglutide. The drug is the active ingredient in Novo Nordisk's blockbuster diabetes medicine Ozempic, which has also gained global attention for its weight loss effects. A Division Bench of Justice C. Hari Shankar and Justice Om Prakash Shukla upheld a Single Judge's order refusing...